Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

55.54 -1.53 (-2.68%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Smart Money Is Betting Big In CVS Options
Via Benzinga
Wall Street Closes At Record Highs After Reassurance From Powell: Magnificent 7 Hit $17 Trillion, Treasury Yields Erase Post-Election Spike
The U.S. 
Via Benzinga
Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday?
An “everything rally” powered Wall Street on Wednesday after the 2024 election results, with Donald Trump emerging as the clear presidential winner. 
Via Benzinga
Topics Government
Exposures Political
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Via Benzinga
CVS Health (CVS) Q3 2024 Earnings Call Transcript
CVS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
Market surges to record highs after Trump's election, Republicans win Senate majority. Tech and small-caps up, VIX drops 22%. 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
What the Options Market Tells Us About CVS Health
Via Benzinga
CVS Health Stock Jumps After Mixed Q3 Earnings, Takes $1.2 Billion Restructuring Charges Hit
CVS Health posted Q3 sales of $95.43 billion, driven by gains in Health Care Benefits. The company revised leadership roles and withdrew its 2024 guidance amid financial challenges. 
Via Benzinga
CVS Reports Mixed Q3 Results: Revenue Beats Forecast, Earnings Decline
CVS Health Corporation reported a 6.3% increase in total revenues for the third quarter of 2024, reaching $95.4 billion. 
Via Talk Markets
Dow, Nasdaq Futures Race Higher As Trump Wins White House: DJT, Tesla Shares Surge — Veteran Investor Predicts US Economy Could 'Take Off'
U.S. stocks could witness a strong opening on Wednesday after former President Donald Trump emerged victorious after a long-drawn battle with Joe Biden and Kamala Harris. 
Via Benzinga
Topics Economy Government Stocks
Exposures Economy Political US Equities
Dow, Nasdaq Jump Over 1% Ahead Of Election Results: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Where CVS Health Stands With Analysts
Via Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios. 
Via MarketBeat
Is Realty Income a Buy, Sell, or Hold in 2025?
This leading REIT could be an attractive dividend play again. 
Via The Motley Fool
CVS Health Q3 Earnings Preview: Can The Company Overcome Recent Challenges?
CVS Health is preparing to report Q3 earnings after cutting its annual profit guidance and implementing leadership changes. 
Via Benzinga
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Cigna Considers Humana Acquisition – What It Means for the Stocks
Rumors swirl around a potential Cigna (CI) and Humana (HUM) merger, but Medicare Advantage costs pose a significant challenge, making the merger risky. 
Via MarketBeat
Hims & Hers Stock Dropped: Here's What You Need to Know
The GLP-1 drama continues at Hims & Hers. 
Via The Motley Fool
Walmart Launches Same-Day Pharmacy Delivery, Upping Competition For CVS, Walgreens
Walmart announced on Tuesday that it will begin offering Pharmacy Delivery services both new prescriptions and medication refills, intensifying competition in the pharmacy retail space. 
Via Benzinga
ASML's Latest Chapter in the Semiconductor Story
We've also got a look at genetic testing company 23andMe . 
Via The Motley Fool
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery. 
Via MarketBeat
CVS Health Preannounces Large Earnings Miss, But Analysts Stay Bullish On Long-Term Recovery
CVS Health Corp (NYSE: CVS) preannounces earnings miss for Q3. Analysts maintain ratings after CEO change. 
Via Benzinga
Topics Earnings
Exposures Financial
Cigna And Humana Revive Early Merger Talks After Year-Long Pause As Medicare Cost Pressure Looms
Cigna and Humana are in early-stage merger discussions after a year-long pause. Amid financial pressure, Humana's Medicare Advantage star ratings have plummeted, impacting future revenue. 
Via Benzinga
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
10 worst performing stocks last week: NIO -16.35%, KLAC -15.58%, CNC -14.38%, Elevance -14.17%, ASML -13.97%, PDD -13.91%, MOH -12.24%, LRCX -12.12%, ERIE -9.92%, CVS -9.44% 
Via Benzinga
2 "Safe" Healthcare Stocks That Are Anything But
If you buy these stocks, you might be in for serious disappointment when they underperform. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.